Same-Day Appointments | Physician-Directed Care | Telehealth 7 Days | Medicaid Accepted | $125 Self-Pay
Medically Reviewed & Written By: Dr. Saleha Jafar, MD | Board-Certified: Addiction Medicine | Internal Medicine | Obesity Medicine Last updated Dec 2025

Sublocade® 300mg injection administered in our Frisco,TX clinic once monthly by our licensed providers
If you are looking to start "Sublocade® injection in Frisco, TX" or considering to switch from Suboxone to Sublocade,Medivira is your answer. Unlike high-volume corporate clinics, Medivira is one of a few clinics offering Individualized MAT for Opioid Use disorder (OUD) with Long acting monthly Sublocade® injections at our Frisco, TX clinic with direct access to your doctor in between appointments via 24/7 text support so you're never on your own between every step of the transition
Serving Frisco, Plano, McKinney, Allen, Prosper, Celina;we accept Texas Medicaid and most major insurance plans, and offer a free first consultation to determine whether Sublocade® is the right fit for you
Sublocade (buprenorphine) is a long acting, once-monthly, extended release injection, administered by a healthcare provider and is used to treat opioid use disorder (OUD). It is a partial agonist and works by binding to brain Mu-opioid receptors, reducing withdrawal symptoms and cravings while blocking the euphoric effects of other opioids.
Unlike Suboxone, which must be taken every day, Sublocade® is injected once a month by Dr. Jafar at our Frisco clinic. The medication uses an ATRIGEL® extended-release delivery system that forms a small depot under the skin, slowly releasing buprenorphine at a consistent rate throughout the month — eliminating the daily peaks and troughs that come with oral medication.
Sublocade® is FDA-approved and is only available through a certified healthcare provider — it cannot be dispensed at retail pharmacies. At Medivira, Dr. Jafar is a certified Sublocade® provider serving patients across Frisco, Collin County, and greater North Texas.
Patients in Frisco often ask: Is Sublocade available near me? The answer is yes — Medivira offers Sublocade® injections at our Frisco clinic at 400 Stonebrook Pkwy STE 902, with same-day and Telehealth appointments available Monday through Sunday 9am–9pm
The once-monthly injection provides steady buprenorphine levels, helping to manage cravings and withdrawal for a month, unlike daily oral medications.
Clinical Studies have shown good success results (24 weeks): Around 28-30% of patients on Sublocade plus counseling achieved treatment success vs. 2% on placebo and 75 % of patients remained abstinent from illicit opioids for a year after completing 12 monthly injections.
Similarly Treatment retention rates of 85% at six months and 75% at one year are significantly better than other treatments like Suboxone. Success rates significantly increase when Sublocade combined with behavioral therapies and counseling

Sources: Clinical trials published in The Lancet . Treatment outcomes at Medivira align with national clinical benchmarks for Sublocade® therapy.
| Administration | Daily sublingual film or tablet | Once-monthly injection by physician |
| Contains | Buprenorphine + Naloxone | Buprenorphine only |
| Daily adherence | Required — missed doses create gaps | None — one injection covers the month |
| When to start | Can be used early in treatment | Requires stability on buprenorphine first |
| Diversion risk | Higher — can be shared or sold | None — administered in clinic only |
| Misuse risk | Present despite naloxone | Very low — injected by physician |
| 1-year retention | Lower | 75% — significantly higher |
| Dosing flexibility | More flexible adjustments | Standardized monthly dosing |
| Best suited for | Early recovery, frequent dose changes | Stable patients ready to simplify treatment |
Why do people switch from Suboxone to Sublocade?
People may have various reasons for switching from Suboxone to Sublocade
● No longer having to take daily medications
● Reduced risk of misuse
● Adverse reactions to naloxone
● Wanting more consistent buprenorphine levels throughout the month
● Privacy — no daily medication as a visible reminder of treatment
● Better long-term retention and abstinence outcomes
● Simplifying life — one clinic visit per month instead of daily management
● Currently stable on Suboxone and ready for the next step in recovery
Sublocade or Suboxone: Which One Works Better?
Both are highly effective. Sublocade (monthly injection) is generally better for patients needing consistent dosing and compliance without daily medication management. Suboxone (daily film/tablet) offers more flexibility for dosage adjustments, particularly in early recovery.
For patients in Frisco, TX who are already stable on Suboxone and looking to simplify their recovery journey, Sublocade® is frequently the superior long-term option. Dr. Jafar will help you determine which treatment best fits your specific medical history, lifestyle, and recovery goals during your free initial consultation
Sublocade® is not for everyone — it is specifically designed for patients who are already stable on Suboxone (buprenorphine/naloxone) and ready to simplify their treatment. You may be a good candidate if:
• You are currently on Suboxone and your opioid use is stable
• You find it difficult to remember or maintain a daily medication routine
• You want to eliminate the risk of missing doses or running out of medication
• You are concerned about privacy and do not want daily reminders of your treatment
• You want the highest retention rates and best long-term outcomes
• You are looking to switch from Suboxone to Sublocade in Frisco, TX
Not sure if you qualify? Dr. Jafar offers a free initial consultation to evaluate whether Sublocade® is the right next step in your recovery. Same-day appointments available.
just minutes from Stonebriar Centre & The Star in Frisco
Discreet, private care in a professional medical setting
Telehealth-with minimal waiting room time
Seamless transfer for patients already on Suboxone & want to transfer from previous provider to Medivira
Personalized treatment plans, not a high-volume clinic
Board certified doctors with years of experience, focused on long-term recovery and mental wellness
long acting injectable, Sublocade® MAT available
Medivira accepts most major insurance plans for Sublocade® treatment, including:
• Texas Medicaid
• Medicare
• Blue Cross Blue Shield
• Aetna, Cigna, UnitedHealthcare
• Obamacare / ACA marketplace plans
• Most commercial insurance plans
No insurance? Self-pay clinic visits at Medivira are $125 — one of the lowest physician-led rates in Frisco, TX. The cost of the Sublocade® medication itself is typically covered by insurance. Ask us about the Sublocade® patient assistance program if cost is a concern
I have to say hands down she's one of the most caring doctors one could go to! She's warm, takes time to listen & understand, makes sure her patients do not leave with any unanswered questions. The best of all She Truly Cares About Her Patients- hard to find a genuine doctor like her!!
I became a patient less than a year ago and was relieved to have found the perfect doctor from the very first visit. Dr. Jafar provides old-fashioned personal care with new-fashioned expertise, rare in today's medical environment. She is very intelligent, a very good doctor, and a very nice person. Her office manager and assistant complement Dr. Jafar perfectly, combining efficiency with grace and humanity. One could not ask for a better experience.
Dr. Jafar is an amazing woman. I swear she has saved my life!! I walked in her office desperate for help to change my life and I walked in the right door. With addiction having a huge stigma in society it is difficult to find a place to go where you will not be judged n treated with compassion n respect. She takes her time to listen to your needs and her care plan has given me my life back Thankyou Dr. Jafar and your staff for your excellent professional care n understanding. I am so grateful and blessed to be your patient and have found a new healthy way to live!!!

Dr SALEHA JAFAR,MD
is the President and Founder of Medivira
She completed her residency at University of Pittsburgh Medical Center (UPMC) in 1998. Dr. Saleha Jafar is Triple Board certified in Addiction Medicine, Internal Medicine and Obesity Medicine.
She has 27 years of Medical Experience.
She is a member of AMA (American Medical Association), ASAM (American Society of Addiction Medicine) and TMA
Call, text, or book online for a free consultation with Dr. Jafar. She will review your current Suboxone treatment, assess your eligibility for Sublocade®, and explain the full transition process. Same-day appointments are available.
To begin Sublocade®, patients must already be on a stable dose of buprenorphine (Suboxone or generic). Dr. Jafar will confirm your current dose and ensure you have no signs of opioid withdrawal before the first injection.
Your first Sublocade® injection is administered by Dr. Jafar at our Frisco clinic. The injection is given subcutaneously in the abdomen. The procedure takes just minutes and you will be monitored briefly before leaving.
After your first injection, you return once a month for your next dose. Follow-up visits are quick — typically 15–20 minutes. Telehealth check-ins between injections are also available to monitor your progress and address any questions.
It is a rapid onset of intense opioid withdrawal symptoms caused by taking the medication too soon after using full-agonist opioids like Heroin, Fentanyl, Percocets
Vomiting
Diarrhea
muscle aches,fever
sweating
rapid heart rate
agitation, anxiety
Medivira's Sublocade® clinic is located at 400 Stonebrook Pkwy, STE 902, Frisco, TX 75036 — just minutes from Stonebriar Centre and The Star in Frisco. We serve patients from across the greater DFW area, including:
• Frisco, TX
• Plano, TX
• McKinney, TX
• Allen, TX
• Prosper, TX
• Little Elm, TX
• The Colony, TX
• Celina, TX
• Lewisville, TX
If you are searching for 'Sublocade injection near me' anywhere in Collin County, Denton County, or the greater Dallas-Fort Worth area — Medivira's Frisco clinic has you covered. Call or book online today
Sublocade® is a once-monthly buprenorphine extended-release injection used to treat opioid use disorder (OUD). Unlike daily pills or films, Sublocade® is injected subcutaneously, just under the skin by a licensed provider. It forms a solid depot that slowly releases buprenorphine into the bloodstream over 30 days, reducing cravings and withdrawal symptoms without the risk of missing daily doses.
Medivira offers Sublocade® injections in Frisco, TX. Our licensed providers administer the injection in-office, making it a convenient and discreet option for patients in Frisco, Plano, McKinney, Allen, and the surrounding North Dallas area
Sublocade® is administered once every month, with at least 26 days between doses. After your first two 300mg injections, your provider at Medivira in Frisco will determine whether to continue at 300mg or move to a 100mg monthly maintenance dose based on your individual response and treatment goals
Yes. The FDA approved a rapid initiation protocol in 2025 that allows treatment to begin after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm tolerability. If you are already taking buprenorphine, you can switch to your first Sublocade® injection the same day. Medivira in Frisco, TX offers same-day starts for eligible patients.
Sublocade® can be administered subcutaneously in the abdomen, thigh, buttock, or back of the upper arm. Injection sites are rotated between doses. The injection is given only by a certified healthcare provider and cannot be self-administered at home.
For many patients, yes. Sublocade® eliminates the need to take a daily medication, which removes the risk of forgetting doses, misuse, or diversion. Clinical trials published in The Lancet and NEJM show that 75% of patients remained in treatment at one year and 75% were opioid-free one year after completing treatment — outcomes that are difficult to achieve with daily oral medications alone.
Both medications contain buprenorphine, but they are delivered very differently. Suboxone® is a daily film placed under the tongue that also contains naloxone. Sublocade® is a once monthly injection administered by a provider in a clinical setting. Sublocade® does not require daily adherence, cannot be diverted or misused at home, and maintains stable medication levels throughout the month with no daily peaks or drops.
Both are monthly injections used for opioid use disorder, but they work differently. Vivitrol® contains naltrexone, a full opioid blocker, and requires a patient to be completely opioid-free before starting. otherwise it can trigger severe withdrawal. Sublocade® contains buprenorphine, a partial opioid agonist, and can be started as soon as early signs of withdrawal appear, without requiring a full detox period first.
No. Sublocade® contains buprenorphine, a partial opioid agonist with a ceiling effect, meaning it does not produce euphoria at therapeutic doses. Because it is injected subcutaneously and released slowly over 30 days, it maintains stable blood levels that control cravings without producing a high.
Yes. Medivira's Frisco, TX location is conveniently located for patients traveling from Plano, McKinney, Allen, Little Elm, The Colony, Prosper, and Celina. Our office serves the greater North Dallas area for opioid use disorder treatment including Sublocade® injections.
Getting started is simple. Contact Medivira in Frisco, TX to schedule a confidential evaluation with one of our licensed providers. We will review your medical history, confirm your eligibility for Sublocade®, verify your insurance, and get your first injection scheduled — all in a judgment-free, supportive environment.
Yes, and this is completely normal. After the injection, Sublocade® changes to a solid form called a depot, which may be seen or felt as a small bump under the skin at the injection site for several weeks. It will gradually decrease in size over time. You should not try to remove it or rub the injection site.
After achieving steady state, patients who stop Sublocade® may have detectable plasma and urine levels of buprenorphine for 12 months or longer, depending on how long they were on treatment and the dose received. This is important to disclose if you are undergoing drug testing for employment or legal purposes.
No. While buprenorphine is available as a generic drug in tablet form, there is currently no generic version of Sublocade®. The injectable extended-release formulation is proprietary to Indivior and is not available as a generic.
Sublocade® is covered by many major insurance plans, including Medicaid and Medicare in Texas. Coverage varies by plan. The team at Medivira in Frisco, TX can help verify your insurance benefits before your first appointment so there are no surprises.
Yes, and it is strongly recommended. Treatment that combines medication and counseling has been shown to be effective. Counseling can help people deal with the behaviors and emotions that are often linked to addiction and can teach long-term skills to cope with stressful situations. At Medivira in Frisco, we treat the whole person — not just the medication side of recovery.
Common side effects include injection site reactions such as itching, redness, or a lump under the skin. Other possible side effects include nausea, headache, constipation, and fatigue. Rare but serious risks include liver problems, breathing difficulties, or severe allergic reactions. Your Medivira provider will review your full medical history before starting treatment and monitor you regularly throughout.
To qualify, patients must have a diagnosis of moderate-to-severe opioid use disorder and must tolerate an initial dose of transmucosal buprenorphine prior to receiving their first injection. A full medical evaluation is required. At Medivira in Frisco, TX, we guide patients through every step of the qualification and onboarding process.
References:Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00488-1/fulltext
Medivira 400 Stonebrook Pkwy, STE 902 Frisco, TX 75036 Tel:+1469-888-8241
Last updated: March 2026
© 2026 All Rights Reserved.